2000
DOI: 10.1097/00003086-200012000-00032
|View full text |Cite
|
Sign up to set email alerts
|

Thromboprophylaxis Using a Low Molecular Weight Heparin Delays Fracture Repair

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
63
2
2

Year Published

2006
2006
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 66 publications
(69 citation statements)
references
References 15 publications
1
63
2
2
Order By: Relevance
“…LMWHs are replacing heparins for many indications in Europe and for limited indications in North America 1 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…LMWHs are replacing heparins for many indications in Europe and for limited indications in North America 1 .…”
Section: Discussionmentioning
confidence: 99%
“…Deep vein thrombosis occurs in 50% to 70% of patients undergoing major lower limb orthopedics surgery, in patients with acute spinal injury or multiple traumas without prophylaxis 1 . After almost three decades of intensive research, low-molecularweight heparins (LMWH) have established their niche as an important class of antithrombotic compounds.…”
Section: Introductionmentioning
confidence: 99%
“…At the beginning of this study, we thought that heparin and the enoxaparin would affect fracture healing negatively but fondaparinux that has positive effects on osteoblasts according to the previous papers would effect positively on fracture healing (6)(7)(8)(9)(10)(11)(12). Hereby, fondaparinux would be used in traumatic patients with fractures safely as an antiembolic agent was a part of our hypothesis.…”
Section: Discussionmentioning
confidence: 88%
“…At the 7 th POD, a higher breaking strength was observed for the study group in relation to the control one (p=0.01). This fact could be explained by a better angiogenesis of rats treated with enoxaparin, once heparin is associated with the activation of fibroblasts growth factors, epidermal growth and especially vascular endothelial growth 10,11,12,13 . This latter would be the main factor for the vascular neoformation stimulus 13,14,15,16 .…”
Section: Discussionmentioning
confidence: 99%
“…This heparin presents high capacity to inhibit the Xa factor, weak anti-IIa or anti-thrombin activity, lower affinity for plasmatic and vascular proteins, endothelial cells, macrophages and platelets, granting higher availability and plasmatic half-life and reduction on the side effects associated with thrombocytopeny and risk of bleeding when compared to non-fractioned heparins 6,7,8 . Besides its anticoagulant action, heparin presents several biological activities such as antiinflammatory action, immunological modulation and activation of vascular endothelial growth factors, fibroblasts growth factors and epidermal growth associated to heparin, all vital for healing 10,11,12,13 . Heparin also regulates angiogenesis and presents a chemotactic effect for endothelial cells in human cells cultures by enhancing the growth factor activity resulting in stimulus to vascular neoformation 13,14,15,16 .…”
Section: Introductionmentioning
confidence: 99%